Globus Medical is a leading musculoskeletal solutions company dedicated to solving unmet clinical needs and changing lives. Founded in 2003, the company develops, manufactures, and distributes state-of-the-art musculoskeletal device products that enable surgeons to promote healing in patients with musculoskeletal disorders. With a singular focus on advancing surgery, Globus Medical has become one of the fastest-growing companies in the history of orthopedics, driving significant technological advancements across a complete suite of spine, trauma, and robotic products.
The company's innovative portfolio includes ExcelsiusGPS™ robotic navigation technology, comprehensive spine procedure solutions, orthopedic trauma systems, joint reconstruction products, and regenerative biologics. Globus Medical operates with approximately 5,300-6,000 employees and is publicly traded on the New York Stock Exchange (NYSE: GMED). Through its MERC Academy and state-of-the-art research laboratories, the company partners with healthcare professionals to deliver best-in-class educational frameworks and pioneering clinical research, ultimately improving patient care and surgical outcomes worldwide.